Does Rallies track congressional trades in KVUE?

Yes. Rallies tracks politician and congressional stock disclosures for KVUE, including reported purchases, sales, dates, owners, and trade amounts when available.

Is KVUE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KVUE. It does not provide personalized investment advice.

KVUE (Kenvue Inc.) Stock Analysis - Politician Trades

Kenvue Inc. (KVUE) is a publicly traded Consumer Defensive sector company. As of May 20, 2026, KVUE trades at $17.23 with a market cap of $32.99B and a P/E ratio of 20.16. KVUE moved +1.05% today. Year to date, KVUE is +2.97%; over the trailing twelve months it is -28.22%. Its 52-week range spans $14.02 to $25.17. Analyst consensus is neutral with an average price target of $18.67. Rallies surfaces KVUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded KVUE stock?

Recent politician trading activity in KVUE includes disclosures from Gilbert Cisneros, Gilbert Cisneros, Gilbert Cisneros, Lisa McClain, and Val Hoyle. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

KVUE Key Metrics

Key financial metrics for KVUE
Metric	Value
Price	$17.23
Market Cap	$32.99B
P/E Ratio	20.16
EPS	$0.86
Dividend Yield	0.21%
52-Week High	$25.17
52-Week Low	$14.02
Volume	10.28M
Avg Volume	0
Revenue (TTM)	$15.29B
Net Income	$1.62B
Gross Margin	58.37%

Congressional Trades in KVUE

Gilbert Cisneros purchase KVUE on Feb 10, 2026 (amount: $15.00K).
Gilbert Cisneros sale KVUE on Jan 9, 2026 (amount: $15.00K).
Gilbert Cisneros purchase KVUE on Nov 12, 2025 (amount: $15.00K).
Lisa McClain purchase KVUE on Sep 25, 2025 (amount: $15.00K) for Spouse.
Val Hoyle sale KVUE on Sep 23, 2025 (amount: $15.00K) for Spouse.

Latest KVUE News

Kimberly-Clark Sets Four Segments, Guides $31.6B Combined Business with New CEO-COO Duo — Apr 15, 2026
Kenvue jumps as traders price in Kimberly-Clark $21.01 takeout after vote approval — Apr 8, 2026
Kenvue slides as Tylenol autism-risk litigation flares and deal spread widens — Apr 7, 2026
FDA Approves Leucovorin for Rare CFD-FOLR1 Disorder; Price Targets Raised to $18–$20 — Mar 10, 2026
Grocery Outlet Shares Plunge 23% After Q4 EPS Miss, Reveals 36 Store Closures — Mar 5, 2026

Recent KVUE Insider Trades

Orlando Matthew sold 38.49K (~$679.69K) on May 8, 2026.
Smith Jeffrey C bought 3.20M (~$55.59M) on Dec 12, 2025.
Smith Jeffrey C bought 3.18M (~$55.39M) on Dec 11, 2025.

KVUE Analyst Consensus

7 analysts cover KVUE: 0 strong buy, 0 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $18.67.

Common questions about KVUE

Which politicians traded KVUE stock?: Recent politician trading activity in KVUE includes disclosures from Gilbert Cisneros, Gilbert Cisneros, Gilbert Cisneros, Lisa McClain, and Val Hoyle. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in KVUE?: Yes. Rallies tracks politician and congressional stock disclosures for KVUE, including reported purchases, sales, dates, owners, and trade amounts when available.
Is KVUE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KVUE. It does not provide personalized investment advice.